BioSpace News Archive

Disc Medicine, a clinical-stage biotechnology company dedicated to the discovery and development of novel therapies for the treatment of serious and debilitating hematologic diseases, announced a $90 million Series B financing from a leading syndicate of investors.

Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced that the Company will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 10 at 12:30pm ET.

Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced that Dr Megan Baldwin, the Company’s Chief Executive Officer, will participate in the following investor conferences in September:

CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced the Company plans to participate in the 2021 Wells Fargo Healthcare Conference and H.C. Wainwright 23rd Annual Global Investment Conference.

Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 2:00 p.m. EDT.

Chemomab Therapeutics Ltd., a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for inflammatory and fibrotic diseases with high unmet need, announced it has appointed Dale R. Pfost, PhD, as Chief Executive Officer.

Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced that members of its management team will participate in three upcoming virtual investor conferences.

Ionis Pharmaceuticals, Inc. announced that management will present a company overview at the following virtual investor conferences:.

Gamida Cell Ltd., an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, announced that company management will present its corporate highlights at the following virtual investor conferences in September.

AddexTherapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that CEO, Tim Dyer, will present a corporate overview at the Swiss Biotech Day, held September 7, 2021 at the Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland.